Results 131 to 140 of about 12,251 (152)

Drugs Acting on DNA Topoisomerases: Recent Advances and Future Perspectives

Current Pharmaceutical Design, 1999
Barbara Gatto, Manlio Palumbo, Giovanni Capranico   +2 more
exaly  

Separation and functional analysis of eukaryotic DNA topoisomerases by chromatography and electrophoresis

Biomedical Applications, 1996
Tobias Straub, Friedrich Boege, Birgitta Ruth Knudsen   +2 more
exaly  

DNA Topoisomerases of Leishmania Parasites; Druggable Targets for Drug Discovery

Current Medicinal Chemistry, 2019
CARLOS Garcia-Estrada, Rosa M Reguera, Rafael Balaña-Fouce   +2 more
exaly  

DNA topoisomerases

Current Opinion in Structural Biology, 1991
openaire   +1 more source

Quinolones, 2-Pyridones and Resistant Type II DNA Topoisomerases

Current Pharmaceutical Design, 1997
Linus L Shen, Daniel T W Chu, S Ken Tanaka   +2 more
exaly  

DNA Topoisomerases

1994
Raymond K. Ralph, Warren Judd, Yves Pommier, Kurt W. Kohn   +3 more
openaire   +1 more source

Structure and mechanism of action of type IA DNA topoisomerases

Biochemistry (Moscow), 2010
, D V Bugreev, Nevinsky G A
exaly  

Nuclear DNA Topoisomerases inPisum sativumL.

Journal of Experimental Botany, 1993
Donato Chiatante, J A Bryant, Bryant J A   +2 more
exaly  

DNA topoisomerases I and II inhibitory activity of constituents isolated fromJuglans mandshurica

Archives of Pharmacal Research, 2003
Gao Li, Mi-Hee Woo, Jong-Keun Son
exaly  

Type II DNA Topoisomerases as Antibacterial Targets

Current Pharmaceutical Design, 1996
exaly